| 000 | 03074nam a22004095i 4500 | ||
|---|---|---|---|
| 999 |
_c11379 _d11379 |
||
| 001 | 11379 | ||
| 003 | DE-He213 | ||
| 005 | 20210706040350.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 180704s2018 si | s |||| 0|eng d | ||
| 020 | _a9789811069437 | ||
| 024 | 7 |
_a10.1007/978-981-10-6943-7 _2doi |
|
| 040 |
_aES-MaUEC _bspa _dES-VaUE |
||
| 050 | 4 |
_aRC280 _b.M36 2018 EB |
|
| 245 | 0 | 0 |
_aManagement of Advanced Prostate Cancer _cedited by Choung Soo Kim. |
| 264 | 1 |
_aSingapore _bSpringer Singapore : _bImprint: Springer _c2018. |
|
| 300 | _a1 recurso en línea (IX, 201 páginas 11 ilustraciones, 8 ilustraciones a color) | ||
| 336 |
_2rdacontent _aTexto (visual) _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 347 |
_atext file _bPDF |
||
| 490 | 0 | _aMedicine (Springer-11650) | |
| 505 | 0 | _aSection 1. Surgery for advanced prostate cancer -- Section 2 Radiotherapy for advanced prostate cancer -- Section 3. Androgen deprivation therapy for advanced prostate cancer -- Section 4. Chemotherapy and immunotherapy and palliative care for advanced prostate cancer. | |
| 520 | 3 | _aThis textbook summarizes the state of the art in the management of locally advanced and metastatic prostate cancer with the aim of providing the knowledge required for optimal treatment decision making in individual cases. Readers will find comprehensive coverage of the latest developments in surgery, radiotherapy, androgen deprivation therapy (ADT), chemotherapy, and immunotherapy. The role of the hormonal therapies abiraterone and enzalutamide and docetaxel-based chemotherapy in castration-resistant prostate cancer and hormone-sensitive metastatic disease is carefully evaluated. Among the other therapies discussed are LHRH agonists and antagonists, cabazitaxel, radium-223, and various novel agents still under clinical trials. The section on surgical approaches addresses, among other topics, the use of robot-assisted radical prostatectomy, pelvic lymphadenectomy, and the benefits of adjuvant and neoadjuvant therapy. The current role of external beam radiotherapy, alone or in combination with ADT and brachytherapy, for locally advanced disease is reviewed. Management of Advanced Prostate Cancer will be a valuable resource for practitioners at all levels of expertise. | |
| 988 | _aEBSPRINGER_2018 | ||
| 650 | 7 |
_aOncología _9139207 _2embne |
|
| 650 | 7 |
_aPróstata _xCáncer _9182337 _2embne |
|
| 700 | 1 |
_aKim, Choung Soo. _eeditor literario |
|
| 710 | 2 |
_aSpringerLink (Online service) _0http://id.loc.gov/authorities/names/no2005046756 _0http://viaf.org/viaf/148105729 _9106996 |
|
| 776 | 0 | 8 |
_iEdición impresa: _z9789811069420 |
| 776 | 0 | 8 |
_iEdición impresa: _z9789811069444 |
| 776 | 0 | 8 |
_iEdición impresa: _z9789811329333 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-10-6943-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Valencia) |
| 942 |
_2lcc _cLE |
||
| 998 |
_db _feng _ggw _h0 |
||